Rite Aid Corporation reached an agreement in principle with certain of its senior secured noteholders on the terms of a financial restructuring plan that will allow the company to accelerate its ongoing business transformation. Implementing the contemplated restructuring plan will significantly reduce the company’s debt, increase its financial flexibility and enable it to execute on key initiatives. In connection with this, Rite Aid has initiated a voluntary court-supervised process under Chapter 11 of the U.S. Bankruptcy Code.

Rite Aid is continuing to deliver healthcare products and services across its retail and online platforms for the nearly one million customers it serves daily. The company remains committed to improving health outcomes and delivering on its purpose to help people achieve whole health for life.

The court-supervised process provides an orderly and efficient forum for Rite Aid to:

  • Finalize and build consensus for the agreement in principle the company has reached with certain of its senior secured noteholders
  • Accelerate the company’s store footprint optimization plan
  • Implement a proposed transaction under which MedImpact would acquire Elixir Solutions, subject to the outcome of a court-approved marketing process
  • Access additional liquidity
  • Resolve litigation claims in an equitable manner

In connection with this process, Rite Aid has received a commitment for $3.45 billion in new financing from certain of its lenders. This financing is expected to provide sufficient liquidity to support the company throughout this process.

Additionally, Rite Aid today appointed Jeffrey S. Stein as CEO, chief restructuring officer and a member of the company’s board of directors, effective immediately. Stein is an experienced corporate leader and executive director with significant expertise in supporting companies that are driving meaningful business transformations and undergoing financial restructurings. He succeeds Elizabeth Burr, who has served as interim CEO since January 2023. Burr will continue in her role as a director on the company’s board.

“Rite Aid has served customers and communities across our country for more than 60 years, and the important actions we are taking today will enable us to move ahead as a stronger company,” Stein said. “With the support of our lenders, we look forward to strengthening our financial foundation, advancing our transformation initiatives and accelerating the execution of our turnaround strategy. In doing so, we will be even better able to deliver the healthcare products and services our customers and their families rely on – now and into the future.

“We remain focused on serving our customers and communities, and we are grateful that they continue to choose our stores and pharmacies for their healthcare needs. We thank our associates for their ongoing hard work and dedication, and we extend our gratitude to our partners, suppliers and vendors for their continued support.”

Reducing Debt and Enhancing Financial Flexibility

The company has reached an agreement in principle with certain of its senior secured noteholders on the terms of a financial restructuring that would significantly reduce the company’s debt.

Rite Aid intends to use the court-supervised process to finalize the agreement in principle, build additional consensus for the financial restructuring plan it contemplates and implement it as quickly and efficiently as possible.

Optimizing the Company’s Store Footprint

Rite Aid regularly evaluates its store portfolio to ensure it is operating efficiently while meeting the needs of its customers, communities and associates. In connection with the court-supervised process, the company will continue assessing its footprint and close additional underperforming stores. These efforts will further reduce the company’s rent expense and are expected to strengthen its overall financial performance.

“The court-supervised process provides Rite Aid with legal tools to accelerate our footprint optimization in an efficient and orderly manner,” Stein said. “We look forward to working closely with our landlords to determine the best path forward for each of our stores.”

The company is making every effort to ensure customers of impacted stores have access to health services, whether at another Rite Aid or a nearby pharmacy, and will work to transfer prescriptions accordingly so that there is no disruption of services. The company will also transfer associates at impacted stores to other Rite Aid locations where possible.

A&G Realty Partners is assisting the company with its store closing and lease restructuring program.

Serving Elixir Clients, Plan Sponsors, Members and Customers While Conducting a Sale Process

Rite Aid has entered into an agreement with MedImpact Healthcare Systems, an independent pharmacy benefit solutions company, pursuant to which MedImpact will acquire Rite Aid’s Elixir Solutions business. Under the terms of the agreement, MedImpact will serve as the “stalking horse bidder” in a court-supervised sale process under section 363 of the U.S. Bankruptcy Code. Accordingly, the proposed transaction is subject to higher and better offers, court approval and other customary conditions.

Elixir Solutions is operating normally and continuing to serve clients, plan sponsors, members and customers as usual.

Rite Aid and certain of its subsidiaries, including those that comprise Elixir Solutions, have filed voluntary petitions for reorganization under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of New Jersey. Elixir Insurance is not included in the Chapter 11 process.

The company has filed a number of customary motions with the court seeking authorization to support its operations, including the payment of employee wages, salaries and benefits without interruption. The company expects to receive court approval for these requests shortly. The company intends to pay vendors and suppliers in full for goods and services provided on or after the filing date.

Kirkland & Ellis is serving as legal advisor, Guggenheim Securities is serving as investment banker and Alvarez & Marsal is serving as transformation officer and financial advisor to the company.